Shire (SHPG -0.2%) lags the overall market after JP Morgan/Cazenove cut the shares to Neutral,...

|About: Shire PLC (SHPG)|By:, SA News Editor

Shire (SHPG -0.2%) lags the overall market after JP Morgan/Cazenove cut the shares to Neutral, citing a lack of catalysts. The firm says its pipeline is now a 2014 story, as its Phase III studies of Vyvanse for depression, as well as versus Concerta for ADHD, aren't likely to have any impact over the near term.